Feng Chi BiotechROCO:6744 -0.97%82 Gross Margin % is 43.36% as of Dec. 2025, which is 3% below its 10-year median of 44.90. GuruFocus rates ROCO:6744 with a GF Score™ of 82/100 and a GF Value™ of NT$20.84 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 732 Biotechnology companies, Feng Chi Biotech ranks worse than 65.57% on this metric.
Feng Chi Biotech Corp gross margin has been in long-term decline. The average rate of decline per year is -1.3%.
The historical rank and industry rank for Feng Chi Biotech's Gross Margin % or its related term are showing as below:
ROCO:6744'
s Gross Margin % Range Over the Past 10 Years
Min: 41.44 Med: 44.9 Max: 49.28
Current: 44.63
During the past 10 years, the highestGross Margin % of Feng Chi Biotech was 49.28%. The lowest was 41.44%. And the median was 44.90%.
ROCO:6744's Gross Margin % is ranked worse than 65.57% of 732
companies
in the Biotechnology industry
Industry Median: 60.91
vs ROCO:6744: 44.63
Feng Chi Biotech had a gross margin of 43.36% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Feng Chi Biotech was -1.30% per year.
Feng Chi Biotech (ROCO:6744) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Feng Chi Biotech had a gross margin of 43.36% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Feng Chi Biotech Gross Margin % Related Terms
Feng Chi Biotech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Feng Chi Biotech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6744 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Feng Chi Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Feng Chi Biotech Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Feng Chi Biotech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Feng Chi Biotech (ROCO:6744) has a Gross Margin % of 43.36% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Feng Chi Biotech and its competitors. This is near median its historical median of 44.90. Over the past decade, Feng Chi Biotech's Gross Margin % has ranged from 41.44 to 49.28. According to the industry distribution chart, Feng Chi Biotech ranks #480 out of 732 companies in the Biotechnology industry, placing it in the top 65.6%.
Is Feng Chi Biotech's Gross Margin % too high?
Feng Chi Biotech's current Gross Margin % of 43.36% is near median its 10-year median of 44.90. Over the past 10 years, this metric has ranged from a low of 41.44 to a high of 49.28. The Biotechnology industry median Gross Margin % is 60.91. Feng Chi Biotech's value of 43.36% is 28.8% below this industry median. Based on the distribution chart, Feng Chi Biotech ranks #480 out of 732 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Feng Chi Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Feng Chi Biotech ranks #480 out of 732 companies for Gross Margin %. This places Feng Chi Biotech in the lower half of its industry. The industry median Gross Margin % is 60.91. Feng Chi Biotech's value of 43.36% is 28.8% below this benchmark. Historically, Feng Chi Biotech's own Gross Margin % has ranged from 41.44 to 49.28 over the past decade. While the company's 10-year median is 44.90 vs. the industry median of 60.91, Feng Chi Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Feng Chi Biotech's current Gross Margin % of 43.36% is 28.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Feng Chi Biotech and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feng Chi Biotech's current Gross Margin % is 43.36%, which is near median its own 10-year median of 44.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$20.84, compared to a current price of NT$15.35 — trading 26.3% below its estimated fair value. The current Gross Margin % is 43.36%, which is near median its 10-year median of 44.90 and 28.8% below the Biotechnology industry median of 60.91. Feng Chi Biotech's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current Gross Margin % is 43.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?
Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued.
The current stock price of NT$15.35 is trading 26.3% below its estimated GF Value™ of NT$20.84.
GuruFocus considers Feng Chi Biotech to be Modestly Undervalued.
Key valuation signals for ROCO:6744:
Gross Margin %: 43.36% (near median its 10-year median of 44.90)
GF Value™: NT$20.84 vs. price of NT$15.35 (26.3% below fair value)
Industry Position: 28.8% below the Biotechnology median (#480 of 732)
No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
82GF Score
Get the complete analysis for ROCO:6744
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6744 has been successfully added to your 
